Optina Diagnostics

Visit Company

A simple eye scan to detect a key biomarker of Alzheimer’s disease. Optina Dx is developing a ground-breaking tool utilizing deep learning algorithms for identifying beta-amyloid (AB) plaques, a key biomarker of this disease.

Company News:

September 05, 2018

DIAGNOS Partners with Optina Diagnostics, a Montreal Based Company, to Provide a Web Platform for the Early Detection of Alzheimer Disease. Read More